Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer.
Journal: JCI insight
Published: October 03, 2024
Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.
Journal: Nature communications
Published: March 13, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026